|
|
Article: Stanford University to Study Genomics-Based Diagnostic Test for Uncertain Tumors.
- Article from:
- PR Newswire
- Article date:
- May 6, 2008
CopyrightCOPYRIGHT 2008 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The Pathwork(R) Tissue of Origin Test is Designed to Increase Diagnostic Certainty For Hard-to-Identify Tumors
SUNNYVALE, Calif., May 6 /PRNewswire/ -- Pathwork Diagnostics, Inc., a molecular diagnostics company focused on oncology, announced today that Stanford University School of Medicine has initiated an investigational study of the Pathwork(R) Tissue of Origin Test. The new test uses advanced genomics-based technology to help physicians determine a tumor's origin in order to optimize cancer-specific treatment. The study will evaluate the test's ability to impact diagnosis for cancer patients with hard-to-identify tumors, with test samples processed at the ...
Related newspaper, magazine, and journal articles:
|
|
Article: Pathwork Diagnostics, Inc. Chooses Univa UD For ...
Business Wire;
March 24, 2009 ;
700+ words
... ... environments, announced today that Pathwork Diagnostics, Inc., a molecular diagnostics ... computing capacity at peak times. Pathwork Diagnostics develops molecular diagnostic tests ... Ljubomir Buturovic, Chief Scientist at Pathwork Diagnostics. "With UniCloud and Amazon EC2 ...
|
|